Allena Pharmaceuticals, Inc.

No description available

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Notification of late filing of Form 10-Q

Notification of removal from listing and/or registration on a national securities exchange

3.01

1.02,1.03,3.01,5.02

3.01

General form for quarterly reports under Section 13 or 15(d)

8.01,9.01

5.07

Additional Information for Proxy Statement/ Votes

1.01,3.02,3.03,5.03,8.01,9.01

Additional Information for Proxy Statement/ Votes

1.01,9.01

Prospectus Supplement for Primary Offering

2.02,8.01,9.01

8.01,9.01

Additional Information for Proxy Statement/ Votes

1.02

Registration (IPO) statement under Securities Act of 1933

1.02

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

06b

General form for quarterly reports under Section 13 or 15(d)

Preliminary Proxy Statement

1.01,3.02,3.03,5.03,8.01,9.01

Additional Information for Proxy Statement/ Votes

Prospectus Supplement for Primary Offering

Annual report pursuant to Section 13 or 15(d) (amendment)

Annual report pursuant to Section 13 or 15(d)

Other Events

3.01,8.01

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

5.02,9.01

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

2.02,8.01,9.01

1.01,1.02,8.01,9.01

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Letter from the SEC

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d) (amendment)

General form for quarterly reports under Section 13 or 15(d) (amendment)

General form for quarterly reports under Section 13 or 15(d) (amendment)

Correspondence with the SEC

2.02,9.01

Letter from the SEC

8.01,9.01

3.01

General form for quarterly reports under Section 13 or 15(d)

Prospectus Supplement for Primary Offering

Additional Information for Proxy Statement/ Votes

General form for quarterly reports under Section 13 or 15(d)

Notice of Effectiveness

Correspondence with the SEC

Letter from the SEC

Additional Information for Proxy Statement/ Votes

Registration statement under Securities Act of 1933

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Prospectus Supplement for Primary Offering

Annual report pursuant to Section 13 or 15(d)

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Notice of Effectiveness

Prospectus Supplement for Primary Offering

Correspondence with the SEC

Letter from the SEC

Free Writing Prospectus

Free Writing Prospectus

Prospectus Supplement for Primary Offering

Free Writing Prospectus

Registration statement under Securities Act of 1933

General form for quarterly reports under Section 13 or 15(d)

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d) (amendment)

Annual report pursuant to Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Correspondence with the SEC

Letter from the SEC

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

No description available

No description available

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Draft registration statement (confidential submission) (amendment)

No description available

Draft registration statement (confidential submission) (amendment)

Letter from the SEC

Draft registration statement (confidential submission)

Katz Richard D

BRENNER LOUIS MD

BRENNER LOUIS MD

Alexander Robert

SANTINI GINO

Margolin Alexey L

Diaz Allene M.

Miller Ann Calby

BRENNER LOUIS MD

Fitzpatrick Mark J.

Fitzpatrick Mark J.

BRENNER LOUIS MD

Katz Richard D

Katz Richard D